Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
WYETH ExteNET : Essai de phase 3 randomisé, en double aveugle, évaluant l’efficacité du neratinib, après un traitement par trastuzumab, chez des patientes ayant un cancer du sein HER2+. [essai clos aux inclusions] https://www.kusajili.fr:443/Trial/3KSNzlTiLESLbCKWslMhqw%24wyeth-extenet-essai-de-phase-3-randomise-en-double-aveugle-evaluant-lefficacite-du-neratinib-apres-un-traitement-par-trastuzuma
I have read and accept the terms of use of the site and the Privacy Policy
Send your message